🇺🇸 FDA
Patent

US 6376654

Myeloma cell and ovarian cancer cell surface glycoproteins, antibodies thereto, and uses thereof

expired A61KA61K2039/505A61P

Quick answer

US patent 6376654 (Myeloma cell and ovarian cancer cell surface glycoproteins, antibodies thereto, and uses thereof) held by Molecular Discoveries, Inc. expires Mon Apr 18 2022 00:00:00 GMT+0000 (Coordinated Universal Time). Status: expired.

Key facts

Applicant
Molecular Discoveries, Inc.
Grant date
Tue Apr 23 2002 00:00:00 GMT+0000 (Coordinated Universal Time)
Expiration
Mon Apr 18 2022 00:00:00 GMT+0000 (Coordinated Universal Time)
Claims
5
CPC classes
A61K, A61K2039/505, A61P, A61P15/00, A61P19/00